CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 214603-214816
Annnotations
CORD-19-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1679 | 0-213 | Sentence | denotes | In vitro studies suggest that TLV exhibits superior antibacterial potency relative to vancomycin (VAN); this may be due to the lipophilic decylaminoethyl side chain that targets TLV to the bacterial cell membrane. |
T83055 | 0-213 | Sentence | denotes | In vitro studies suggest that TLV exhibits superior antibacterial potency relative to vancomycin (VAN); this may be due to the lipophilic decylaminoethyl side chain that targets TLV to the bacterial cell membrane. |
CORD-19_Custom_license_subset
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T144 | 0-213 | Sentence | denotes | In vitro studies suggest that TLV exhibits superior antibacterial potency relative to vancomycin (VAN); this may be due to the lipophilic decylaminoethyl side chain that targets TLV to the bacterial cell membrane. |
Epistemic_Statements
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T474 | 0-213 | Epistemic_statement | denotes | In vitro studies suggest that TLV exhibits superior antibacterial potency relative to vancomycin (VAN); this may be due to the lipophilic decylaminoethyl side chain that targets TLV to the bacterial cell membrane. |